A study protocol of the effectiveness of the Attempted Suicide Short Intervention Program (ASSIP) for recent suicide attempters: a randomized controlled trial.
Sara Lindström, Anna Ehnvall, Erik Bergqvist...
https://pubmed.ncbi.nlm.nih.gov/39367366Actively Recruiting
Phase Not Applicable
Age: 18Years +
All Genders
ID04746261
A Randomized Clinical Study of Attempted Suicide Short Intervention Program (ASSIP) in Swedish Healthcare
Led by Region Skane · Updated on 2025-08-20
460
Participants Needed
2
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the Attempted Suicide Short Intervention Program (ASSIP) to prevent future suicidal behavior in people who have recently attempted suicide. This multicenter, randomized controlled trial in Sweden aims to compare ASSIP as a supplement to usual psychiatric care versus usual care alone. The study also explores factors that may influence ASSIP's effectiveness and assesses its cost-effectiveness. Participants receive either ASSIP plus standard treatment or standard treatment alone. ASSIP involves up to four therapy sessions, including a videotaped narrative interview, video playback with discussion, development of a personalized prevention plan, and an optional mini-exposure session. Therapists also send standardized letters to participants over two years to maintain contact. Standard treatment includes multidisciplinary care such as psychotherapy, medication, and referrals to specialist or primary care as needed. Participants undergo baseline interviews and self-assessments, followed by telephone interviews and self-assessment scales at 3, 12, and 24 months. Researchers collect data from medical records, national health and social insurance registers, and track suicide attempts and health outcomes over two years. The primary outcomes include the number of suicide attempts and cost-effectiveness over this period, with secondary measures covering suicidal thoughts, quality of life, healthcare use, and employment status.
CONDITIONS
Brief Title
A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Signed informed consent to participate in the study
- Contact with psychiatric healthcare after a suicide attempt within 3 months before baseline visit
- Booked follow-up appointment in psychiatry or primary care after first visit
You will not qualify if you...
- Current psychotic illness with delusions, hallucinations, or symptoms affecting therapy
- Known emotionally unstable personality disorder noted in medical records
- Inability to participate in therapy without an interpreter
- Mental retardation, dementia, or other conditions preventing understanding of study participation and consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 24 months
Participants receive either the Attempted Suicide Short Intervention Program (ASSIP) plus treatment as usual, or treatment as usual alone, which involves multidisciplinary care including psychotherapy, pharmacotherapy, and referrals as needed. The ASSIP intervention includes up to four therapy sessions and standardized letters for follow-up contact over two years.
Initial baseline visit followed by regular contacts including therapy sessions and follow-up letters over two years
Follow-up
Duration - 24 months after inclusion
Participants are assessed through structured telephone interviews, self-rating scales, and medical record reviews at 3, 12, and 24 months after the initial visit to evaluate outcomes including suicide attempts, suicidal thoughts, healthcare contacts, and quality of life.
3 follow-up assessments via telephone and medical record reviews at 3, 12, and 24 months
Trial Site Locations
Total: 2 locations
1
Region Skåne, psykiatri & habilitering, psykiatriforskning skane, Vuxenpsykiatri Lud
Lund, Sweden
Actively Recruiting
2
Region Skåne, psykiatri & habilitering, psykiatriforskning skane,Vuxenpsykiatri Malmoe
Malmö, Sweden
Not Yet Recruiting
Loading map...
Research Team
Å
Åsa Westrin, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here